We used a large population based case series, Studies of Epidemiology and Risk factors in Cancer Heredity (SEARCH), and a retrospective cohort design to compute FRRs separately for relatives of patients with different tumour subtypes, primarily ER-positive and ER-negative disease, but also subtypes defined by PR and HER2, where data were available. This evidence concerns the gene ESR1 and cancer.